3-Bromomethylphenidate (3-Br-MPH) is a compound from the
phenidate family, which has reportedly been sold as a
designer drug. It showed the most potent binding to the
dopamine transporter of a series of ring-substituted methylphenidate derivatives, and produced
stimulant effects in animal studies.[1][2][3]
^Pan D, Gatley SJ, Dewey SL, Chen R, Alexoff DA, Ding YS, Fowler JS (October 1994). "Binding of bromine-substituted analogs of methylphenidate to monoamine transporters". European Journal of Pharmacology. 264 (2): 177–82.
doi:
10.1016/0014-2999(94)00460-9.
PMID7851480.
^Deutsch HM, Shi Q, Gruszecka-Kowalik E, Schweri MM (March 1996). "Synthesis and pharmacology of potential cocaine antagonists. 2. Structure-activity relationship studies of aromatic ring-substituted methylphenidate analogs". Journal of Medicinal Chemistry. 39 (6): 1201–9.
doi:
10.1021/jm950697c.
PMID8632426.
^Misra M, Shi Q, Ye X, Gruszecka-Kowalik E, Bu W, Liu Z, et al. (October 2010). "Quantitative structure-activity relationship studies of threo-methylphenidate analogs". Bioorganic & Medicinal Chemistry. 18 (20): 7221–38.
doi:
10.1016/j.bmc.2010.08.034.
PMID20846865.